Browse Pharmaceutical industry topic

Health aspects subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words CytRx to Initiate Phase 2 Clinical Trial with INNO-206 in Patients with Advanced Gastric Cancer. Nov 18, 2009 1118 Alnylam Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer. Nov 18, 2009 1185 AnaptysBio Names Director of Cell Biology; Joins from Regeneron, Adds Extensive Therapeutic Antibody Discovery Credentials. Nov 17, 2009 398 PPD and Janssen Pharmaceutica Collaborate to Develop Compounds for Treatment of Irritable Bowel Syndrome and Bacterial Infections. Clinical report Nov 16, 2009 685 Aradigm Doses First Patient in Long-Term Phase 2 Study of a Novel Inhaled Ciprofloxacin Formulation for the Management of Respiratory Infections in Bronchiectasis. Nov 16, 2009 696 BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antibodies. Nov 13, 2009 510 BioAlliance Pharma Presents Results for Its New Oral Chemotherapy Nanoparticle Innovation at the AAPS Annual Meeting in Los Angeles, November 8 to 12, 2009. Nov 12, 2009 665 Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference. Conference news Nov 11, 2009 718 Millennium Laboratories Announces Five Drug Screening Tests to Help Pain Physicians with Therapeutic Patient Care. Nov 11, 2009 902 BioAlliance Pharma: Epidemiological study on Oropharyngeal Candidiasis and results on miconazole MBT* compliance were presented at the 51st ASTRO Annual Meeting. Nov 5, 2009 556 Alnylam and Roche Advance RNAi Therapeutic Collaboration Phase of Landmark 2007 Alliance. Nov 4, 2009 1001 Alnylam Presents New Pre-Clinical Data on ALN-TTR, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis. Nov 2, 2009 1169 Pain free 1-2-3! Eliminating fibromyalgia pain. Teitelbaum, Jacob Clinical report Nov 1, 2009 5187 United States : European panel reviewing infections linked to Tysabri. Oct 26, 2009 273 New Animal Study Featured in the Journal of Cellular Biochemistry Supports Rexahn's Archexin[TM] as Potent Inhibitor of Human Cancer Cell Growth. Oct 22, 2009 573 Analysis Group Promotes Preeminent Epidemiologist to Managing Principal. Oct 22, 2009 338 Girard Gibbs LLP and the Danko Law Firm File a Federal Lawsuit against the Makers of Yaz and Yasmin. Oct 22, 2009 554 KAI Reports Positive Preclinical Results in Pain Therapeutic Program Targeting Gamma Protein Kinase C (PKC) Pathway. Financial report Oct 20, 2009 610 Halsa Pharmaceuticals Receives $750,000 Payment from Texas ETF to Develop Therapeutic Weight-loss Treatment. Oct 14, 2009 669 Parker Waichman Alonso LLP Continues to Fight for Those Sickened by Zinc-Containing Denture Adhesive Creams and Files Suit Against GlaxoSmithKline on Behalf of a Super PoliGrip[R] User Diagnosed with Neuropathy. Oct 8, 2009 557 Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-2125, a TLR9 Agonist, in Combination with Ribavirin for Chronic Hepatitis C Virus Infection. Oct 7, 2009 904 United States: AVI BioPharma gets $11.5M military contract. Oct 6, 2009 262 Allergan Files Federal Lawsuit to Allow It to Share Relevant Information with the Medical Community on the Safe Use of BOTOX[R] for Common Therapeutic Off-Label Treatments. Oct 2, 2009 2079 Cannabis Science Updates Progress For Its Phytocannabinoid Pharmaceutical Products To Help Reduce ARDS-Associated Deaths From Both The Avian And Swine Influenza Infections. Sep 21, 2009 831 Alnylam and Medtronic Present New Late-Stage Pre-clinical Data on ALN-HTT, an RNAi Therapeutic for the Treatment of Huntington's Disease. Sep 15, 2009 1458 Research and Markets: Prostate Cancer Therapy Area Pipeline Report: Status of Prostate Cancer Drugs by Company and by Stage and Summary of the Latest News and Developments. Report Sep 11, 2009 352 Research and Markets: Ovarian Cancer Therapy Area Pipeline Report. Report Sep 11, 2009 352 Cempra Pharmaceuticals Initiates Phase 2/3 Clinical Study for an Oral Antibiotic to Treat Acute Bacterial Skin Structure Infections. Clinical report Sep 9, 2009 506 Research and Markets: Herpes Simplex Virus Infection Therapy Area Pipeline Report. Report Sep 9, 2009 360 Enabling Capabilities of Inovio Biomedical's Electroporation Delivery Technology with SIV DNA Vaccine Confirmed in Collaborative Study With National Cancer Institute. Report Sep 3, 2009 1227 Research and Markets: Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report - Drug Status by Company and by Stage as Well as a Summary of the Latest News and Developments. Report Aug 25, 2009 350 Research and Markets: Head and Neck Cancer Therapy Area Pipeline Report - Detailed Information on the Head and Neck Cancer Drug Pipeline. Report Aug 12, 2009 360 Research and Markets: Breast Cancer Therapy Area Pipeline Report: Extensive Details on Drug Pipelines by Company and Stage and Latest Company News. Report Aug 12, 2009 352 United Kingdom : Forest Laboratories, AstraZeneca sign deal to develop, sell treatment for infections. Aug 12, 2009 168 United States : Molecular Insight Pharmaceuticals, Inc. Advances Azedra Program Into Pivotal Phase 2 Therapeutic Trial in Neuroendocrine Cancer Patients. Aug 8, 2009 445 Low cholesterol can increase risk to cancer: Study. Aug 6, 2009 483 The protected addiction: exploring staff beliefs toward integrating tobacco dependence into substance abuse treatment services. Teater, Barbra; Hammond, Gretchen Clark Aug 1, 2009 5663 Vertex Pharmaceuticals and Mitsubishi Tanabe Pharma Corporation Amend Agreement to Develop and Commercialize Telaprevir in Asia. Jul 30, 2009 1179 Acceleron and Celgene Initiate Phase 2 Study of ACE-011 to Treat Chemotherapy-Induced Anemia. Jul 28, 2009 725 CytoDyn Completes Safety Testing of Cytolin[R]: Benchmark for Improved Treatment of HIV/AIDS. Jul 22, 2009 701 BioAlliance Pharma Signs a Co-Promotion Agreement with Lundbeck for in-Hospital Prescription of the Antidepressant Seroplex[R]. Jul 21, 2009 399 7 Deadly myths. Kirman, Irena; Middleton, Jeremy; Kilpatrick, Laura E. Letter to the editor Jul 1, 2009 930 Screening for Ovarian Cancer: One. Jul 1, 2009 883 Screening for Ovarian Cancer: One "Scissor Step" Made. Jul 1, 2009 887 CMs' role in a pandemic is to keep patients educated. Jul 1, 2009 695 Tysabri infection. Jun 30, 2009 63 BioSante Pharmaceuticals Comments on Study Showing No Increased Risk of Breast Cancer in Women Using Testosterone for Low Libido. Jun 29, 2009 926 Research and Markets: Bladder Cancer Therapy Area Pipeline Report - A Detailed Information on the Bladder Cancer Drug Pipeline. Report Jun 12, 2009 313 Special Feature: Swing and Miss?!? Efforts in Front-line Ovarian Cancer Chemotherapy Development. Jun 1, 2009 1370 Research and Markets: Cancer Drug Discoveries: What the Future Holds for the Non-Small Cell Lung Cancer Market and Therapeutic Approaches. May 26, 2009 774 Upcoming BioAlliance Pharma's Presentations at International Conferences on Infectious Diseases and Oncology. Conference news May 19, 2009 499 Bioalliance Pharma Presents Results for Its New Oral Irinotecan Nanoparticle Formulation for the Treatment of Advanced Colorectal Cancer at the American Association for Cancer Research (AACR) 100Th Annual Meeting in Denver, April 18 to 22, 2009. Apr 22, 2009 562 Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection. Apr 21, 2009 1663 AVEO Announces Positive Finding for Triple VEGF Receptor Inhibitor AV-951 in Preclinical Model of Liver Cancer. Apr 21, 2009 884 Warning on latest diet pill effects; HEALTH. Apr 20, 2009 123 Ensemble Discovery Initiates Collaboration with Bristol-Myers Squibb to Develop Drugs in Novel Therapeutic Class. Apr 15, 2009 594 The Asian Cardiovascular Market Outlook to 2014: Regional and Therapeutic Analysis, Pipeline Impact and Growth Opportunities. Industry overview Apr 8, 2009 2603 Reportlinker Adds World Cancer Therapies Market Report. Apr 1, 2009 3280 Lymphadenectomy in Early-stage Endometrial Cancer? Apr 1, 2009 995 VGX Pharmaceuticals Announces Agreement With the PATH Malaria Vaccine Initiative. Mar 23, 2009 385 Ecolab Healthcare Expands Infection Control Solutions for Pharmaceutical Operations Through Strategic Partnership. Mar 16, 2009 232 'Hospital visitors may be infection carriers'. Mar 7, 2009 453 Next-Generation Sequencing Uncovers Genetic Variation Linking Type 1 Diabetes with Enterovirus Infection. Mar 5, 2009 1052 Researchers Use 454 Sequencing System for Rapid Sequencing of Avian Influenzas. Mar 4, 2009 804 Optimer Pharmaceuticals to Accelerate European Filing of Fidaxomicin (OPT-80). Mar 2, 2009 681 Caffeine in sunscreen may cut skin cancer risk. Feb 27, 2009 195 Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Australia for All Patients with PNH. Feb 25, 2009 1462 A 454 Sequencing Study Reveals New Insights in Drug Resistance and Tropism Associated with the New HIV Integrase and Entry Inhibitor Therapy Classes. Clinical report Feb 18, 2009 1066 VGX Pharmaceuticals Proprietary DNA Vaccines Delivered with Electroporation Achieve Immune Responses Superior to Recombinant Adenovirus Serotype 5 (Ad5) Vectors. Feb 18, 2009 600 Phase 1 Trial Begins for Investigational New Drug for MDR Gram-negative Infections. Feb 17, 2009 764 Flamel Technologies Announces Merck Serono's Exercise of Option to License Medusa Technology for Development of an Extended-Release Formulation of a Therapeutic Protein. Feb 17, 2009 626 Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposium. Feb 12, 2009 2643 Cubist Pharmaceuticals Announces Start of First-in-Human Clinical Trial for Investigational New Drug for Clostridium difficile infections. Feb 12, 2009 840 Progenics Selects Subcutaneous Form of PRO 140, a Novel HIV Antibody Therapy, for Further Development. Feb 10, 2009 1867 CHI to Host Congressional Briefing: Biomedical Industry Addresses Health Disparities. Feb 6, 2009 69 Research and Markets: Stem Cell-Based Therapeutic Delivery: Challenges & Opportunities. Feb 6, 2009 298 Bioalliance Pharma Presents Results on a New Quinoline Family on HIV Integrase Inhibitors at the 16Th Conference on Retroviruses and Opportunistic Infections (CROI). Conference news Feb 6, 2009 587 AnaptysBio Names Vice President to Lead Therapeutic Antibody Preclinical Development Efforts. Feb 3, 2009 472 Alnylam and Collaborators at Harvard Medical School Demonstrate In Vivo Silencing of Key Genes Implicated in the Transmission of Herpes Simplex Virus-2 (HSV-2). Jan 21, 2009 965 Seek Better Options Says Expert After Cancer Risks Raise Doubts About Popular Osteoporosis Drugs. Jan 15, 2009 374 Quintiles Takes Action to Speed Development of Cancer Therapies. Jan 14, 2009 615 Alnylam Provides Key Goals and Guidance for 2009. Jan 12, 2009 1855 Alnylam and Cubist Form Strategic Collaboration to Develop and Commercialize RNAi Therapeutics Targeting Respiratory Syncytial Virus (RSV) Infection. Jan 9, 2009 2007 Howard Feldman Joins Bristol-Myers Squibb as Vice President and Therapeutic Area Head, Global Clinical Research, Neuroscience. Jan 8, 2009 427 Get a Deep Insight into the World Therapeutic Apheresis Market. Jan 6, 2009 1478 Cubist Pharmaceuticals, the Developer of CUBICIN, Announces Submission of 2 INDs Targeting Serious Infections Caused by MDR Gram-negative Pathogens and by Clostridium difficile. Jan 5, 2009 1021 Cancer risk tied to drugs taken for bone health. Jan 3, 2009 420 The highest hygiene standards, to budget and on time. Jan 1, 2009 203 GTx Submits New Drug Application for Toremifene 80 mg for the Prevention of Bone Fractures in Men with Prostate Cancer on Androgen Deprivation Therapy. Dec 30, 2008 1199 Alnylam Advances RNAi Therapeutics Pipeline and Files Company's First Systemic Delivery IND. Dec 23, 2008 1180 Inovio Biomedical's Advances in Electroporation-Delivered Therapeutic Vaccines Presented at International DNA Vaccine Conference. Conference news Dec 17, 2008 1290 SDI and MedImmune Publish Ground-Breaking Study on Geographically Specific, Seasonal RSV Disease Outbreak Data. Dec 15, 2008 1164 Alnylam Forms Collaboration with University of California, San Francisco (UCSF) to Investigate Therapeutic Silencing of Key Gene Implicated in Uveal Melanoma. Dec 10, 2008 1186 HIV vaccine fails to give promising results. Dec 3, 2008 413 HIV vaccine fails to give promising results. Nov 25, 2008 413 Intensified Competition in Severe Fungal Infections Drug Market. Nov 1, 2008 350 Cancer drug is used by Angiotech as new CVC anti-infective. Jan 1, 2008 799 Pfizer announces approval of antibiotic. Mar 1, 1998 200 Worksite wellness program targets osteoporosis. Apr 1, 1997 810 Indigent Care Models. Dec 31, 1996 989